We are excited for the future. With the climax of the development process of our flagship product, Autothermo, rigorous testing of functionality and successful authorization permissions obtained, we are headed for our very first on-patient application of Autothermo.
Great thanks to our funders, mentors and the great team that has been behind the entire journey thus far. We are close to realizing our end-goal in improving neonatal survival using technology. We hope and pray for the very best of the process that is at hand. Our clinical trials are scheduled to happen between June and July 2025. Stay tuned for developments on this undertaking.
We are excited to work with a wide range of expertise including;
- Doctors
- Nurses
- Clinicians
- Biomedical Engineers
The data gathered from this crucial study will be used to further inform future design changes pertaining to the development of Autothermo, to improve the usefulness of the device in improving neonatal survival in low and middle income countries.